Cencora, Inc.

Equities

COR

US03073E1055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-05-10 pm EDT			5-day change	1st Jan Change
224.6 ^USD	+0.23%		+0.29%	+9.36%

May. 08	Jefferies Adjusts Price Target on Cencora to $230 From $235	MT
May. 03	Wells Fargo Adjusts Cencora Price Target to $236 From $235	MT

Tranche Update on Cencora, Inc.'s Equity Buyback Plan announced on May 2, 2023.

November 21, 2023 at 04:22 pm EST

From July 1, 2023 to September 30, 2023, the company has repurchased 1,019,661 shares, representing 0.5% for $190.99 million. With this, the company has completed the repurchase of 1,019,661 shares, representing 0.5% for $190.99 million under the buyback announced on May 2, 2023.

Latest news about Cencora, Inc.

Jefferies Adjusts Price Target on Cencora to $230 From $235	May. 08	MT
Wells Fargo Adjusts Cencora Price Target to $236 From $235	May. 03	MT
UBS Adjusts Price Target on Cencora to $275 From $277, Maintains Buy Rating	May. 02	MT
TD Cowen Adjusts Price Target on Cencora to $265 From $261	May. 02	MT
Evercore ISI Adjusts Cencora Price Target to $260 From $270	May. 02	MT
Cencora, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	May. 01	CI
Transcript : Cencora, Inc., Q2 2024 Earnings Call, May 01, 2024	May. 01
Cencora's Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Adjusted EPS Guidance Updated	May. 01	MT
Earnings Flash (COR) CENCORA Posts Q2 Revenue $68.41B, vs. Street Est of $70.78B	May. 01	MT
Earnings Flash (COR) CENCORA Reports Q2 EPS $3.80, vs. Street Est of $3.69	May. 01	MT
Cencora, Inc. announces an Equity Buyback for $2,000 million worth of its shares.	May. 01	CI
Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on May 24, 2024	May. 01	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ
Citigroup Adjusts Price Target on Cencora to $280 From $265	Apr. 30	MT
Mizuho Securities Adjusts Price Target on Cencora to $245 From $224	Apr. 22	MT
Cencora Insider Sold Shares Worth $2,553,860, According to a Recent SEC Filing	Apr. 17	MT
Walgreens Lowers Top End of Fiscal 2024 Earnings Outlook Following Second-Quarter Beat	Mar. 28	MT
Walgreens Boots: reduction in annual targets	Mar. 28	CF
Cencora Insider Sold Shares Worth $2,583,459, According to a Recent SEC Filing	Mar. 21	MT
Cencora Insider Sold Shares Worth $1,661,363, According to a Recent SEC Filing	Mar. 21	MT
Cencora, Inc. Reaffirms Guidance for Year 2024	Mar. 14	CI
Transcript : Cencora, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 08:30 AM	Mar. 14
Cencora Says Steven Collis to Retire as CEO; COO Robert Mauch Named Successor; Guidance Affirmed	Mar. 12	MT
Cencora, Inc. Announces Board Changes, Effective October 1, 2024	Mar. 12	CI
Cencora, Inc. Announces CEO Changes, Effective October 1, 2024	Mar. 12	CI

Chart Cencora, Inc.

Duration

Period

More charts

Company Profile

Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-30 - Q3 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Cencora, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

224.6 USD

Average target price

254.5 USD

Spread / Average Target

+13.30%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
CENCORA, INC.	+9.36%	44.8B
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
HOYA CORPORATION	+2.84%	40.7B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.51%	32.25B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
TERUMO CORPORATION	+15.25%	25.02B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.96B

Other Medical Equipment, Supplies & Distribution